• SB743921: From Mitotic Arrest to Translational Insight

  2026-08-14

  SB743921 is a selective kinesin spindle protein inhibitor that connects a defined mitotic mechanism with a more rigorous framework for measuring cancer drug responses. By separating mitotic arrest, growth inhibition, and cell death, translational researchers can extract more value from in vitro and tumor xenograft models.

• 2-NBDG Glucose Uptake Assay Kit for HCC

  2026-08-13

  Measure transporter-dependent glucose uptake without radioactivity, while using PI and phloretin controls to strengthen interpretation. The 2-NBDG Glucose Uptake Assay Kit is especially useful for connecting metabolic phenotypes with sorafenib response, ferroptosis, and disease-relevant cell models.

• DRD4, Akt/β-Catenin, and Liver Cancer Resistance

  2026-08-13

  The 2024 British Journal of Cancer study identifies DRD4 as a regulator of liver cancer stem cell-like behavior, chemotherapy resistance, and tumorigenicity through the PI3K/Akt/GSK-3β/β-catenin axis. Its integrated expression, patient-association, perturbation, and localization analyses suggest that DRD4-linked signaling may be a tractable vulnerability, while downstream pathway experiments can help distinguish stemness effects from general cytotoxicity.

• Pyridostatin: A Translational G-Quadruplex Strategy

  2026-08-12

  Pyridostatin TFA offers a practical way to connect G-quadruplex stabilization with telomere dysfunction, cancer-cell phenotypes, and more rigorous translational assay design. This thought-leadership framework also explains how recent RNA G-quadruplex findings in TDP-43 biology broaden the research question without overstating the evidence.

• GDC-0994: Selective ERK1/2 Inhibitor Guide

  2026-08-12

  GDC-0994 is a potent, selective ERK1/2 inhibitor for research on MAP kinase signaling, oncogenic RAS/BRAF models, and ERK-dependent tumor cell proliferation. Product data report nanomolar biochemical potency, oral bioavailability, and preclinical activity in KRAS-mutant and BRAF-mutant xenograft models.

• HyperPFU™ high-fidelity DNA polymerase: PCR Guide

  2026-08-11

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, and otherwise difficult DNA templates where conventional PCR enzymes may underperform. Its proofreading activity produces blunt-ended products, so it should not be selected for workflows that require 3′-A overhangs or sticky-end PCR products.

• Mitochondrial Potential as a Translational Cancer Readout

  2026-08-11

  A mechanistic and strategic guide to using ΔΨm as a decision-quality endpoint in cancer research, linking hypoxia-activated Cyclin K degradation and phototherapy with rigorous mitochondrial function analysis, apoptosis assay design, and translational validation.

• From SepM Mechanism to Translational Protein Control

  2026-08-10

  A thought-leadership guide connecting SepM mutation biology in Streptococcus mutans with rigorous protein workflow design. It shows how a Triple color protein ladder can strengthen SDS-PAGE, Western blot, and translational decision-making without overstating what a molecular weight marker can prove.

• Dimetridazole Workflows for AMR Assays

  2026-08-09

  Dimetridazole supports more than a conventional antimicrobial screen: it can reveal membrane injury, combination synergy, quorum-sensing effects, and infection-model responses. This practical guide translates recent multidrug-resistant E. coli findings into reproducible bacterial culture assay, biofilm, and invertebrate workflows.

• Lipid Peroxidation (MDA) Assay Kit for Liver Injury

  2026-08-08

  The Lipid Peroxidation (MDA) Assay Kit provides a practical way to quantify malondialdehyde while placing the result in a mechanistic framework for doxorubicin-induced liver injury. Learn how to combine MDA measurement with ferroptosis, oxidative stress, and autophagy endpoints for stronger biological conclusions.

• SLC2A5 Fructose Metabolism in Primary CNS Lymphoma

  2026-08-07

  This 2026 Advanced Science study uses single-cell RNA and B-cell receptor profiling to connect glucose-poor, hypoxic conditions in primary central nervous system lymphoma with SLC2A5-mediated fructose metabolism. Functional experiments identify SLC2A5 activity in lymphoma cells and tumor-supportive macrophages as a potential metabolic vulnerability, while also linking the microenvironment to T-cell dysfunction.

• Ambroxol Modulation of Nav1.8, TRPV1, and TRPA1 in Neuropath

  2026-08-07

  This study systematically characterizes ambroxol’s modulatory effects on human and rat Nav1.8 sodium channels and the irritant receptors TRPV1 and TRPA1, providing mechanistic insight into its topical analgesic actions. The findings clarify species-specific channel inhibition and reveal that ambroxol can attenuate capsaicin-induced TRPV1 responses, which is relevant for translational research targeting pain signaling pathways.

• Saturated Phosphatidic Acids Drive mTORC1 ISR in Hepatic Glu

  2026-08-06

  This study clarifies how saturated phosphatidic acids trigger mTORC1-mediated integrated stress response (ISR) in hepatocytes, contributing to glucolipotoxicity—a key mechanism in metabolic liver disease. The findings highlight a new molecular link between lipid/glucose overload and hepatocyte death, offering a targeted framework for experimental intervention.

• Beclin1 Deficiency Mitigates DOX-Induced Liver Injury via Fe

  2026-08-06

  This study uncovers the role of Beclin1 in promoting ferroptosis and autophagy during doxorubicin-induced liver injury, demonstrating that Beclin1 deficiency or DHODH overexpression alleviates hepatic oxidative stress and cellular damage. These findings reveal new mechanistic targets for reducing chemotherapeutic hepatotoxicity and refining approaches for oxidative stress biomarker assay and lipid peroxidation measurement.

• Iron-Dependent KDM4D Regulates MSC Quiescence via PI3K-Akt-F

  2026-08-05

  This study uncovers how iron-dependent KDM4D demethylase activity shapes the balance between quiescence and activation in mesenchymal stem cells (MSCs) via the PI3K-Akt-Foxo1 pathway. The findings provide mechanistic insight into the epigenetic impact of iron deficiency on bone metabolism and highlight actionable targets for bone disorder research.

8148 records 2/544 page Previous Next 12345 下5页 Last page